openPR Logo
Press release

Global Gynaecological Cancer Drugs Market To witness significant growth, registering 6.2% CAGR during the forecast period

Global Gynaecological Cancer Drugs Market To witness

The new report by Persistence Market Research (PMR) expects the global gynaecological cancer drugs market to witness significant growth, registering 6.2% CAGR during the forecast period. The global gynaecological cancer drugs market is also expected to bring in US$ 41,855.8 million revenue by the end of 2026.

Treatment of cancer is being increasingly focused on be leading pharmaceutical companies, researchers, healthcare institutes and governments of various countries. With increasing number of research and development activities in cancer treatment, especially in gynaecological cancer treatment, new treatments are reaching an increasing number of physicians faster than ever. Also, availability of advanced treatment options and drugs has resulted in the decline in cancer mortality rate across major developed countries. However, the scenario is not same in the developing nations. This is due to the high cost of cancer treatment and lack of availability of new treatments.

Request to Sample Report @ https://www.persistencemarketresearch.com/samples/21700

New Treatment Options and Robust Pipeline of Drugs in Clinical Development to Drive the Market Growth

According to the American Cancer Society, ovarian cancer ranks fifth resulting in death among women, accounting for a maximum number of deaths compared to any other cancer of female reproductive system. However, over the past 20 years, the number of women diagnosed with ovarian cancer is decreasing. This is due to the discovery of new drugs and treatments for treating gynaecological cancer. Increasing number of drugs have been approved by Food and Drugs Administration (FDA) for gynaecological cancer. Meanwhile, a lot of drugs developed by pharmaceutical firms are under clinical trials. Generic drugs are also gaining traction in the gynaecological cancer drugs market. Meanwhile, personalized medicine approach and targeted therapies also present an opportunity for companies operating in the global gynaecological cancer drugs market.

Global Gynaecological Cancer Drugs Market- Segment-Wise Analysis

The global gynaecological cancer drugs market is segmented into distribution channels, indication, end users, drug class, and region. Based on the drug class, the market is divided into antitumor antibiotic, anthracyclines, plant alkaloid, alkylating agent, and other drug class. Antitumor antibiotic is expected to grow at a faster phase any other drug class. By the end of 2026, antitumor antibiotic is estimated to bring in more than US$ 13,700 million revenue.

By end users, the market segmentation includes specialized cancer treatment centers, clinics, hospitals and others. Among these, hospitals are expected to be the largest users of gynaecological cancer drugs. Hospitals are estimated to exceed US$ 16,300 million revenue towards the end of 2026.

Based on the indication, the market is further segmented into vaginal cancer, vulvar cancer, ovarian & fallopian tube cancer, uterine cancer, and cervical cancer. Uterine cancer is expected to account for the highest revenue share. By the end of 2026, uterine cancer is estimated to exceed US$ 22,500 million revenue.

By distribution channel, the market is divided into e-commerce, retail pharmacies, and hospital pharmacies. Among these, hospital pharmacies are expected to witness the highest growth during the forecast period. Hospital pharmacies are estimated to bring in more than US$ 15,000 million revenue by the end of the forecast period.

North America is expected to be one of the leading regions in the global gynaecological cancer drugs market. Well-developed healthcare infrastructure, presence of the major pharmaceutical companies, increasing investment in the research and development of new drugs and therapies to treat gynaecological cancer are some of the factors contributing to the growth of the market in the region.

Request Report for TOC @ https://www.persistencemarketresearch.com/methodology/21700

Competitive Landscape

Roche Holdings AG, AstraZeneca, Sanofi, Eli Lilly & Co., Pfizer Inc., Takeda Pharmaceuticals Co. Ltd., Bristol-Myers Squibb, Merck & Co., Dr Reddy’s Laboratories, Johnson & Johnson (Alza Corporation), and GlaxoSmithKline (GSK), are some of the leading companies operating in the global gynaecological cancer drugs market.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Gynaecological Cancer Drugs Market To witness significant growth, registering 6.2% CAGR during the forecast period here

News-ID: 1095757 • Views: 217

More Releases from Persistence Market Research Pvt.Ltd.

Dental Restoration Market Present Scenario and the Growth Prospects 2017 - 2025
The term dental restoration covers an integrated management of oral health and restoring the oral health to a functional and esthetic state. The American Dental Association has not considered restorative dentist as a separate specialty though the dentists are able to perform man of these procedures without any additional course or certification. The dental restoration procedures depend on how difficult the procedure is and what the professional feels comfortable with.
Mobile Air Transfer Systems Market Trends and Key Developments 2017 - 2025
Mobile air transfer system is the system used in hospitals and other medical centers that helps to reduce patient handling injury. The system provides patients with simple and comfortable transfer experience along with significantly reducing the cumulative handling effect of thousands of pounds of patients’ weight while routine transfers. To ensure the safety of hundreds of millions of people suffering from health care associated infections and abnormalities mobile air transfer
Orthopedic Veterinary Implants Market is projected to reach US$ 3,500 Mn by 2026
Arthritis is a common disorder which has been recently seen spreading its roots dogs. At present, this diseases is treated with the help of orthopedic veterinary implants. The global orthopedic veterinary implants market has witnessed a substantial surge in the last couple years owing to the rise in pet adoption and their orthopedic surgeries. Majority of the population, especially in the developed regions, own pets such as cats or dogs.
Prepackaged Medical Kits and Trays Market is anticipated to Register a CAGR of 8 …
There has been a Herculean shift in the healthcare industry towards a reformed model and significant rise in investments worldwide is intended to improve various facilities and services across the healthcare industry. The concept of value-based pricing of pharmaceuticals has gained momentum in the last few years and a majority of the OECD countries have adopted this model. This shift has been a crucial component for the revenue growth of

All 5 Releases


More Releases for Drugs

Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.